Lovasa vs Vascepa: Differences?

Lovasa and Vascepa are both prescription forms of omega-3 fatty acids, but they have key differences:

• Lovasa: Contains both EPA and DHA in ethyl ester form. It is indicated for lowering high triglyceride levels but has not been demonstrated to reduce cardiovascular events. The FDA has approved it based on its ability to lower triglycerides, a recognized marker of cardiovascular risk 1.

• Vascepa: Contains only EPA also in ethyl ester form. It is specifically indicated for reducing the risk of cardiovascular events, which sets it apart from Lovasa. Vascepa has demonstrated efficacy in reducing cardiovascular event risks, making it unique among omega-3 fatty acids 1.

The distinction in their composition (EPA only vs. EPA and DHA) and their approved indications (triglyceride reduction vs. cardiovascular risk reduction) are the primary differences between these medications.